Long-Term Assets: The sum of all assets classified as non-current.
InMed Pharmaceuticals Inc. (INM) had Long-Term Assets of $2.71M for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
$4.94M |
|
$-8.16M |
|
$3.24M |
|
$1.71M |
|
$12.86M |
|
$-7.92M |
|
$-0.24M |
|
$-8.16M |
|
$-8.16M |
|
$-8.16M |
|
$-8.16M |
|
$-8.16M |
|
$-8.16M |
|
$-7.92M |
|
$-7.71M |
|
0.98M |
|
0.98M |
|
$-8.36 |
|
$-8.36 |
|
| Balance Sheet Financials | |
$12.87M |
|
$0.99M |
|
|
Long-Term Assets |
$2.71M |
$15.58M |
|
$1.84M |
|
$0.31M |
|
$0.31M |
|
$2.15M |
|
$13.43M |
|
$11.81M |
|
$13.43M |
|
2.00M |
|
| Cash Flow Statement Financials | |
$-7.77M |
|
-- |
|
$12.27M |
|
$6.57M |
|
$11.08M |
|
$4.50M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.99 |
|
-- |
|
-- |
|
0.02 |
|
0.06 |
|
34.53% |
|
-160.20% |
|
-160.20% |
|
-155.89% |
|
-165.14% |
|
-165.14% |
|
$-7.77M |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
3.37 |
|
10.63 |
|
34.35 |
|
-60.76% |
|
-69.09% |
|
-52.39% |
|
-59.40% |
|
$6.71 |
|
$-7.96 |
|
$-7.96 |
|